The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
Open accessAbstract
Toll-like receptors (TLRs) and the downstream adaptor molecule myeloid differentiation factor 88 (MyD88) play an essential role in the innate immune responses. Here, we demonstrate that genetic deficiency of TLR4 or MyD88 is associated with a significant reduction of aortic plaque areas in atherosclerosis-prone apolipoprotein E-deficient mice, despite persistent hypercholesterolemia, implying an important role for the innate immune system in atherogenesis. Apolipoprotein E-deficient mice that also lacked TLR4 or MyD88 demonstrated reduced aortic atherosclerosis that was associated with reductions in circulating levels of proinflammatory cytokines IL-12 or monocyte chemoattractant protein 1, plaque lipid content, numbers of macrophage, and cyclooxygenase 2 immunoreactivity in their plaques. Endothelial-leukocyte adhesion in response to minimally modified low-density lipoprotein was reduced in aortic endothelial cells derived from MyD88-deficient mice. Taken together, our results suggest an important role for TLR4 and MyD88 signaling in atherosclerosis in a hypercholesterolemic mouse model, providing a pathophysiologic link between innate immunity, inflammation, and atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deficiency in either TLR2 or TLR4 signalling also reduced atherosclerotic disease in mouse models35–37, and TLR4, specifically, has been shown to mediate inflammatory responses to free fatty acids,”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [36]
In the citing paper
“TLR signalling is also implicated in the pathogenesis of atherosclerotic disease35–37.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [36]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,996
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574
Research works printed but not linked: 1
- Ameziane, N., Beillat, T., Verpillat, P., Chollet-Martin, S., Aumont, M. C., Seknadji, P., Lamotte, M., Lebret, D., Ollivier, V. & De Prost, D. (2003) Arterioscler. Thromb. Vasc. Biol. 23, 61–64.
Cited by
Sorted by citations
Items 401–500 of 1,000
Nakashima, T., Umemoto, S., Yoshimura, K., Matsuda, S., Itoh, S., Murata, T., Fukai, T., & Matsuzaki, M. (2015) · Hypertension Research · doi:10.1038/hr.2015.55 · Cited by 60
Cheng, X. W., Song, H., Sasaki, T., Hu, L., Inoue, A., Bando, Y., Shi, G., Kuzuya, M., Okumura, K., & Murohara, T. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168385 · Cited by 59
Ehrhardt, N., Doche, M. E., Chen, S., Mao, H. Z., Walsh, M. T., Bedoya, C., Guindi, M. M., Xiong, W., Irudayam, J. I., Iqbal, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx159 · Cited by 60
Self-citationThe Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease
Zhou, Y., Little, P. J., Downey, L., Afroz, R., Wu, Y., Ta, H. T., Xu, S., & Kamato, D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00100 · Cited by 59
Nuclear factor kappaB signaling in macrophage function and atherogenesis
Xanthoulea, S., Curfs, D. M. J., Hofker, M. H., & de Winther, M. P. J. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000180167.15820.ae · Cited by 59
The Impact of Exercise on Immunity, Metabolism, and Atherosclerosis
Meyer-Lindemann, U., Moggio, A., Dutsch, A., Kessler, T., & Sager, H. B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043394 · Cited by 62
Innate immune sensing and activation of cell surface Toll-like receptors
Tapping, R. I. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.003 · Cited by 59
Cross-talk between TLR4-MyD88-NF-κB and SCAP-SREBP2 pathways mediates macrophage foam cell formation
Li, L.-C., Varghese, Z., Moorhead, J. F., Lee, C.-T., Chen, J.-B., & Ruan, X. Z. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00096.2012 · Cited by 56
Patel, P. N., Shah, R. Y., Ferguson, J. F., & Reilly, M. P. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304455 · Cited by 59
Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells
Ishikado, A., Nishio, Y., Yamane, K., Mukose, A., Morino, K., Murakami, Y., Sekine, O., Makino, T., Maegawa, H., & Kashiwagi, A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.010 · Cited by 57
Chen, J., & Stinnett, A. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.92 · Cited by 57
Fredrikson, G. N., Anand, D. V., Hopkins, D., Corder, R., Alm, R., Bengtsson, E., Shah, P. K., Lahiri, A., & Nilsson, J. (2009) · Diabetologia · doi:10.1007/s00125-009-1377-9 · Cited by 57
Self-citationKim, J., Jang, H.-J., & Hwang, D. H. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00369.2015 · Cited by 57
Zhang, R.-N., Pan, Q., Zhang, Z., Cao, H.-X., Shen, F., & Fan, J.-G. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.15(5)2015.27909 · Cited by 56
Watkins, A. A., Yasuda, K., Wilson, G. E., Aprahamian, T. R., Xie, Y., Maganto-García, E., Shukla, P., Oberlander, L., Laskow, B., Menn‐Josephy, H., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402807 · Cited by 57
The role of the vascular dendritic cell network in atherosclerosis
Alberts‐Grill, N., Denning, T. L., Rezvan, A., & Jo, H. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00017.2013 · Cited by 57
Yu, L., Lǐ, Y., Du, C., Zhao, W., Zhang, H., Yang, Y., Sun, A., Song, X., & Feng, Z. (2019) · Mediators of Inflammation · doi:10.1155/2019/5271295 · Cited by 58
TLR4 (Toll-Like Receptor 4) Mediates the Development of Intracranial Aneurysm Rupture
Mitsui, K., Ikedo, T., Kamio, Y., Furukawa, H., Lawton, M. T., & Hashimoto, T. N. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12595 · Cited by 56
Bowen‐Pope, D. F., & Raines, E. W. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179556 · Cited by 61
Schultz, K., Murthy, V., Tatro, J. B., & Beasley, D. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00700.2006 · Cited by 55
Suppression of TLR Signaling by Targeting TIR domain-Containing Proteins
Fekonja, O., Avbelj, M., & Jerala, R. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312804871148 · Cited by 56
Talavera‐Adame, D., Wu, G. D., He, Y., Ng, T. T., Gupta, A., Kurtovic, S., Hwang, J. Y., Farkas, D. L., & Dafoe, D. C. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9232-z · Cited by 56
Lipids and the Endothelium: Bidirectional Interactions
Goldberg, I. J., & Bornfeldt, K. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0365-1 · Cited by 57
Kim, T. W., Febbraio, M., Robinet, P., DuGar, B., Greene, D. J., Cerny, A., Latz, E., Gilmour, R., Staschke, K. A., Chisolm, G. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002242 · Cited by 55
Local Interleukin-1-Driven Joint Pathology Is Dependent on Toll-Like Receptor 4 Activation
Abdollahi‐Roodsaz, S., Joosten, L. A. B., Koenders, M. I., van den Brand, B. T., van de Loo, F. A. J., & van den Berg, W. B. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090262 · Cited by 55
Erridge, C., Webb, D. J., & Spickett, C. M. (2006) · Free Radical Research · doi:10.1080/10715760601070091 · Cited by 55
Wynants, M., Vengethasamy, L., Ronisz, A., Meyns, B. P., Delcroix, M., & Quarck, R. A. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00034.2013 · Cited by 55
Holvoet, P., Davey, P. C., Keyzer, D. D., Doukouré, M., Deridder, E., Bochaton‐Piallat, M., Gabbiani, G., Beaufort, E., Bishay, K., Andrieux, N., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000226553.01555.02 · Cited by 55
Shukla, A. M., & Shukla, A. W. (2019) · Drugs in Context · doi:10.7573/dic.2019-9-1 · Cited by 54
Lipopolysaccharides and Cellular Senescence: Involvement in Atherosclerosis
Suzuki, K., Susaki, E. A., & Nagaoka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911148 · Cited by 55
Tang, Y. L., Jiang, J. H., Wang, S., Liu, Z., Tang, X. Q., Peng, J., Yang, Y.-Z., & Gu, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123685 · Cited by 54
Toll Receptor Polymorphisms and Carotid Artery Intima-Media Thickness
Labrum, R. W., Bevan, S., Sitzer, M., Lorenz, M., & Markus, H. S. (2007) · Stroke · doi:10.1161/01.str.0000260184.85257.2b · Cited by 54
Atherogenic diet-induced hepatitis is partially dependent on murine TLR4
Desai, M. S., Mariscalco, M. M., Tawil, A., Vallejo, J. G., & Smith, C. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607390 · Cited by 54
Jean‐Charles, P., Zhang, L., Wu, J., Han, S.-O., Brian, L., Freedman, N. J., & Shenoy, S. K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.687129 · Cited by 53
Immunomodulation of atherosclerosis with a vaccine
Shah, P. K., Chyu, K., Fredrikson, G. N., & Nilsson, J. Å. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0372 · Cited by 53
Self-citationToll-like Receptor Polymorphisms and Carotid Artery Intima-Media Thickness
Lepper, P. M., von Eynatten, M., Humpert, P. M., Triantafilou, M., & Triantafilou, K. (2007) · Stroke · doi:10.1161/strokeaha.107.487058 · Cited by 53
Jean‐Charles, P., Wu, J., Zhang, L., Kaur, S., Nepliouev, I., Stiber, J. A., Brian, L., Qi, R., Wertman, V., Shenoy, S. K., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311071 · Cited by 53
Endothelial cells: potential novel regulators of renal inflammation
Oates, J. C., Russell, D. L., & Beusecum, J. P. V. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00371.2021 · Cited by 53
Kim, S. Y., Jeong, E., Joung, S. M., & Lee, J. Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.015 · Cited by 52
Barua, R. S., Sharma, M., & Dileepan, K. N. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00572 · Cited by 52
Devaux, C. A., & Raoult, D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01379 · Cited by 53
Nature and nurture of tissue-specific macrophage phenotypes
Hoeksema, M. A., & Glass, C. K. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.10.005 · Cited by 55
Song, Q., Zhang, Y., Han, X., Zhang, Y., Zhang, X., Gao, Y., Zhang, J., Chu, L., & Zhao, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.147 · Cited by 52
Unraveling Host-Gut Microbiota Dialogue and Its Impact on Cholesterol Levels
Villette, R., Pukar, K. C., Béliard, S., Salas-Tapia, M. F., Rainteau, D. P., Guérin, M., & Lesnik, P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00278 · Cited by 55
Lu, Z., Zhang, X., Li, Y., Lopes-Virella, M. F., & Huang, Y. Q. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.06.016 · Cited by 55
Erridge, C., Spickett, C. M., & Webb, D. J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.004 · Cited by 52
Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway.
Chansrichavala, P., Chantharaksri, U., Sritara, P., & Chaiyaroj, S. C. (2009) · PubMed · Cited by 51
Pasini, A. F., Anselmi, M., Garbin, U., Franchi, M. P., Stranieri, C., Nava, M. C., Boccioletti, V., Vassanelli, C., & Cominacini, L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142695 · Cited by 51
Toll-like receptor activity in patients with obstructive sleep apnea
Akinnusi, M. E., Jaoude, P., Kufel, T. J., & El-Solh, A. (2012) · Sleep And Breathing · doi:10.1007/s11325-012-0791-2 · Cited by 53
Regulation of dendritic cell survival and cytokine production by osteoprotegerin
Chino, T., Draves, K. E., & Clark, E. A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708419 · Cited by 51
Innate immunity in CKD-associated vascular diseases
Zewinger, S., Schumann, T., Fliser, D., & Speer, T. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv358 · Cited by 51
Li, Y., Wang, H., Fan, Y., Shi, H., Wang, Q., Chen, B.-R., Khurwolah, M. R., Long, Q., Wang, S., Wang, Z., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481643 · Cited by 51
IL-37 Inhibits the Maturation of Dendritic Cells Through the IL1R8-TLR4-NF-κB Pathway
Liu, T., Liu, J., Lin, Y., Que, B., Chang, C. C., Zhang, J., Liang, Z., Gao, X., Liu, S., Liu, L., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.05.009 · Cited by 51
Jian, X., Liu, Y., Zhao, Z., Zhao, L., Wang, D., & Liu, Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109375 · Cited by 51
The gut microbiota-artery axis: A bridge between dietary lipids and atherosclerosis?
Zhang, Q., Zhang, L., Chen, C., Li, P., & Lu, B. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101209 · Cited by 50
Lappin, D. F., Sherrabeh, S., & Erridge, C. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2011.01702.x · Cited by 50
McNeill, E., Channon, K. M., & Greaves, D. R. (2010) · Clinical Science · doi:10.1042/cs20090488 · Cited by 51
Choi, S., Yin, H., Ravandi, A., Armando, A. M., Dumlao, D. S., Kim, J., Almazan, F., Taylor, A. M., McNamara, C. A., Tsimikas, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083145 · Cited by 50
Polykratis, A., Loo, G., Xanthoulea, S., Hellmich, M., & Pasparakis, M. (2012) · Circulation · doi:10.1161/circulationaha.112.100339 · Cited by 50
Mallick, P., Taneja, G., Moorthy, B., & Ghose, R. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1292251 · Cited by 50
The human microbiota is associated with cardiometabolic risk across the epidemiologic transition
Fei, N., Bernabé, B. P., Lie, L., Baghdan, D., Bedu-Addo, K., Plange‐Rhule, J., Forrester, T., Lambert, E. V., Bovet, P., Gottel, N., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215262 · Cited by 52
Youn, H., Lim, H. J., Lee, H. J., Hwang, D. H., Yang, M., Jeon, R., & Ryu, J. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70434 · Cited by 49
Epigenomic control of the innate immune response
Stender, J. D., & Glass, C. K. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.06.002 · Cited by 50
Role of pattern-recognition receptors in cardiovascular health and disease
Mitchell, J. A., Ryffel, B., Quesniaux, V. F. J., Cartwright, N., & Paul‐Clark, M. J. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351449 · Cited by 49
Feng, Y., Cai, Z., Tang, Y., Hu, G., Jiang, L., He, D., & Wang, S. (2014) · Genetics and Molecular Research · doi:10.4238/2014.january.28.13 · Cited by 49
Erridge, C., Webb, D. J., & Spickett, C. M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.032 · Cited by 49
Lee, J., Lee, S.-H., Park, D., Lee, S., Yoon, H.-S., Chin, B.-R., Kim, J.-H., Kim, J., & Baek, S. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.09.003 · Cited by 49
Ho, C.-C., Luo, Y.-H., Chuang, T., Yang, C., Ling, Y., & Lin, P. (2013) · Toxicology · doi:10.1016/j.tox.2013.03.003 · Cited by 48
The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases—A Review
Keller, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112252 · Cited by 49
Lv, Q., Li, Z., Sui, A., Yang, X., Han, Y., & Yao, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.977187 · Cited by 48
Madenspacher, J. H., Draper, D. W., Smoak, K. A., Li, H., Griffiths, G. L., Suratt, B. T., Wilson, M. D., Rudel, L. L., & Fessler, M. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903501 · Cited by 47
Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models
Jones, D., True, H. D., & Patel, J. (2017) · Mediators of Inflammation · doi:10.1155/2017/9746169 · Cited by 48
NINJ2– A novel regulator of endothelial inflammation and activation
Wang, J., Fa, J., Wang, P., Jia, X., Peng, H., Chen, J., Wang, Y., Wang, C., Chen, Q., Tu, X., et al. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.04.011 · Cited by 48
Wang, Z., Kaplan, R. C., Burk, R. D., & Qi, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212337 · Cited by 48
Zhang, X., Xie, Y., Zhou, H., Xu, Y. T., Liu, J., Xie, H., & Yan, J. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24372 · Cited by 46
The Roles of Pathogen-Associated Molecular Patterns in Atherosclerosis
Erridge, C. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.12.003 · Cited by 46
Role of Toll-Like Receptors in Atherosclerosis
Michelsen, K. S., Doherty, T. M., Shah, P. K., & Arditi, M. (2004) · Circulation Research · doi:10.1161/res.95.12.e96 · Cited by 46
Self-citationRegulatory T Cells and the Control of Modified Lipoprotein Autoimmunity-Driven Atherosclerosis
Nilsson, J. Å., Wigren, M., & Shah, P. K. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2010.02.010 · Cited by 46
Self-citationJongstra‐Bilen, J., Zhang, C., Wisnicki, T., Li, M. K., White-Alfred, S., Ilaalagan, R., Ferri, D., Deonarain, A. R., Wan, M. H., Hyduk, S. J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601363 · Cited by 50
Manček‐Keber, M., Gradišar, H., Pestaña, M. Í., de Tejada, G. M., & Jerala, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003756 · Cited by 46
Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
Kaczorowski, D. J., Nakao, A., McCurry, K. R., & Billiar, T. R. (2009) · Current Cardiology Reviews · doi:10.2174/157340309788970405 · Cited by 46
TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis
Doherty, T. M., Fisher, E. A. A., & Arditi, M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.03.006 · Cited by 46
Self-citationPeriodontal bacteria influence systemic diseases through the gut microbiota
Xi, M., Ruan, Q., Zhong, S., Li, J., Qi, W., Xie, C., Wang, X., Abuduxiku, N., & Ni, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1478362 · Cited by 49
Psoriasis and extra domain A fibronectin loops
McFadden, J. P., Baker, B. S., Powles, A. V., & Fry, L. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09737.x · Cited by 45
Huggins, C., Pearce, S. W. A., Peri, F., Neumann, F., COCKERILL, G. W., & Pirianov, G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.010 · Cited by 45
Karper, J. C., Ewing, M. M., Habets, K. L. L., de Vries, M. R., Peters, E. A. B., van Oeveren‐Rietdijk, A. M., de Boer, H. C., Hamming, J. F., Kuiper, J., Kandimalla, E. R., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.249391 · Cited by 45
Toll-like receptors (TLRs) and immune disorders
Akashi‐Takamura, S., & Miyake, K. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0477-4 · Cited by 45
Korshunov, V. A., Nikonenko, T. A., Va, T., Brooks, A. I., & Berk, B. C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000196544.73761.82 · Cited by 45
Wang, J., Si, Y., Wu, C., Sun, L., Ma, Y., Ge, A.-L., & Li, B. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-139 · Cited by 45
Atherosclerosis and innate immune signaling
Laberge, M. A., Moore, K. J., & Freeman, M. W. (2005) · Annals of Medicine · doi:10.1080/07853890510007304 · Cited by 45
PET/MR imaging of inflammation in atherosclerosis
Senders, M. L., Calcagno, C., Tawakol, A. A., Nahrendorf, M., Mulder, W. J. M., & Fayad, Z. A. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00970-7 · Cited by 46
Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review
Song, D., Fang, G., Greenberg, H. E., & Liu, S. F. (2015) · Immunologic Research · doi:10.1007/s12026-015-8703-8 · Cited by 45
Poulain, L., Richard, V. J., Levy, P. A., Demattéis, M., & Arnaud, C. (2015) · Mediators of Inflammation · doi:10.1155/2015/620258 · Cited by 47
Mehta, N. N., Heffron, S. P., Patel, P. N., Ferguson, J. F., Shah, R. D., Hinkle, C. C., Krishnamoorthy, P. M., Shah, R., Tabita‐Martinez, J., Terembula, K., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-124 · Cited by 45
Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection
Faraj, T. A., McLaughlin, C. L., & Erridge, C. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1280483 · Cited by 46
Rahman, K., & Fisher, E. A. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00032 · Cited by 48
Toll-like receptor 4–deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension
Young, K. C., Hussein, S., Dadiz, R., deMello, D. E., Devia, C., Hehre, D., & Suguihara, C. (2010) · Experimental Lung Research · doi:10.3109/01902140903171610 · Cited by 44
Chen, S., Wong, M. H., Schulte, D. J., Arditi, M., & Michelsen, K. S. (2007) · Journal of Endotoxin Research · doi:10.1177/0968051907085096 · Cited by 46
Self-citationHarari, O., Alcaide, P., Ahl, D., Luscinskas, F. W., & Liao, J. K. (2006) · Circulation Research · doi:10.1161/01.res.0000220105.85182.28 · Cited by 45
Polyphenols from red wine are potent modulators of innate and adaptive immune responsiveness
Magrone, T., & Jirillo, E. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110000121 · Cited by 43
Metadata
- Authors
- Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Arditi, Moshe
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10679-10684
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC489994
- OpenAlex
- W2018788678
- Cited by
- 1,019
- References
- 57
- Citations by year
- 2026: 20 · 2025: 17 · 2024: 25 · 2023: 25 · 2022: 35 · 2021: 21 · 2020: 36 · 2019: 52 · 2018: 36 · 2017: 37 · 2016: 43 · 2015: 64 · 2014: 53 · 2013: 68 · 2012: 68
- FWCI
- 18.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl058555-04)
- National Heart, Lung, and Blood Institute (HL66436, HL 58555, R01HL066436, R29HL051980, HL 51980, R01HL051980)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TLR4, MyD88, atherosclerosis, apolipoprotein E deficiency, innate immunity, atherogenesis, aortic plaque, hypercholesterolemia, inflammatory cytokines, IL-12, MCP-1, macrophages, cyclooxygenase-2, plaque inflammation
- MeSH terms
- Animals, Antigens, Differentiation, Aorta, Apolipoproteins E, Arteriosclerosis, Cells, Cultured, Female, Humans, Immunity, Innate, Isoenzymes, Lipids, Macrophages, Male, Membrane Glycoproteins, Membrane Proteins, Mice, Inbred C57BL, Phenotype, Prostaglandin-Endoperoxide Synthases, Receptors, Cell Surface, Receptors, Immunologic, Signal Transduction, Mice, Knockout, Interleukin-12, Chemokine CCL2, Endothelial Cells, Adaptor Proteins, Signal Transducing, Lipid Metabolism, Toll-Like Receptors, Toll-Like Receptor 4, Mice, Cyclooxygenase 2, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review